萝莉社

(904) 244-0411 Education Research Community

Treats Adults

Michael D Schweitzer Barrios, MD

Pulmonologist, Critical Care Medicine Physician

Request appointment online

Active clinical trials

Phase III, randomized, double-blind, placebo-controlled study to assess BI 1291583 2.5 mg once daily for up to 76 weeks in patients with bronchiectasis

Investigator: Michael D Schweitzer Barrios
Status: Accepting Candidates
Ages: 18 Years - 99 Years
Sexes: All

Phase III Study to Evaluate the Efficacy and Safety of Tezepelumab in Adult Participants with Moderate to Very Severe Chronic Obstructive Pulmonary Disease (JOURNEY)

Investigator: Michael D Schweitzer Barrios
Status: Accepting Candidates
Ages: 40 Years - 80 Years
Sexes: All